Pulmonx Corporation ( LUNG) - Key Metrics
LUNG Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.54 | -$0.24 | -$0.12 | -$0.12 |
| 2026Q1 | $0.49 | -$0.33 | -$0.24 | -$0.24 |
| 2025Q4 | $0.55 | -$0.25 | -$0.17 | -$0.17 |
| 2025Q3 | $0.53 | -$0.34 | -$0.20 | -$0.20 |
| 2025Q2 | $0.59 | -$0.38 | -$0.10 | -$0.10 |
LUNG Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.41 |
| 2026Q1 | 0% | -0.98 |
| 2025Q4 | 0% | -2.21 |
| 2025Q3 | 0% | -1.19 |
| 2025Q2 | 0% | -1.70 |
LUNG
Price: $2.26
52 week price:
Earnings Per Share: -1.15 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 23949
Market Capitalization: 86.6 million